|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 404.56 USD | -4.29% |
|
+3.40% | +15.41% |
| 12:01pm | Elevance Health Reaffirms 2026 Adjusted EPS Guidance | MT |
| 11:33am | (ELV) Elevance Health Expects 2026 Adjusted EPS At Least $26.75, vs. FactSet Est of $26.85 | MT |
Company Valuation: Elevance Health, Inc.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 112,508 | 122,511 | 110,797 | 85,556 | 77,906 | 92,170 | - | - |
| Change | - | 8.89% | -9.56% | -22.78% | -8.94% | 18.31% | - | - |
| Enterprise Value (EV) 1 | 130,384 | 139,238 | 129,391 | 108,500 | 100,461 | 115,794 | 114,952 | 114,015 |
| Change | - | 6.79% | -7.07% | -16.15% | -7.41% | 15.26% | -0.73% | -0.82% |
| P/E ratio | 18.7x | 20.7x | 18.7x | 14.4x | 13.9x | 20.7x | 15.9x | 13.6x |
| PBR | 3.17x | 3.36x | 2.85x | 2.08x | 1.79x | 2.1x | 1.94x | 1.78x |
| PEG | - | 63.99x | 11.32x | 7.89x | -7.59x | -1.1x | 0.5x | 0.8x |
| Capitalization / Revenue | 0.82x | 0.79x | 0.65x | 0.49x | 0.39x | 0.47x | 0.46x | 0.44x |
| EV / Revenue | 0.95x | 0.89x | 0.76x | 0.62x | 0.51x | 0.6x | 0.58x | 0.55x |
| EV / EBITDA | 13x | 12.7x | 10.7x | 8.9x | 9.5x | 11.6x | 11.1x | 10.1x |
| EV / EBIT | 14.2x | 13.9x | 11.5x | 9.54x | 10.4x | 13x | 12.2x | 10.2x |
| EV / FCF | 17.9x | 19.2x | 19.1x | 23.8x | 31.7x | 18.6x | 19.4x | 17.4x |
| FCF Yield | 5.58% | 5.2% | 5.23% | 4.2% | 3.16% | 5.36% | 5.16% | 5.76% |
| Dividend per Share 2 | 4.52 | 5.12 | 5.92 | 6.52 | 6.84 | 6.959 | 7.361 | 7.851 |
| Rate of return | 0.98% | 1% | 1.26% | 1.77% | 1.95% | 1.64% | 1.73% | 1.85% |
| EPS 2 | 24.73 | 24.81 | 25.22 | 25.68 | 25.21 | 20.47 | 26.65 | 31.24 |
| Distribution rate | 18.3% | 20.6% | 23.5% | 25.4% | 27.1% | 34% | 27.6% | 25.1% |
| Net sales 1 | 136,943 | 155,660 | 170,209 | 175,204 | 197,584 | 194,222 | 198,490 | 208,699 |
| EBITDA 1 | 10,011 | 10,924 | 12,114 | 12,191 | 10,574 | 9,941 | 10,354 | 11,238 |
| EBIT 1 | 9,150 | 10,016 | 11,254 | 11,378 | 9,656 | 8,886 | 9,433 | 11,135 |
| Net income 1 | 6,104 | 6,025 | 5,987 | 5,980 | 5,662 | 4,498 | 5,707 | 6,532 |
| Net Debt 1 | 17,876 | 16,727 | 18,594 | 22,944 | 22,555 | 23,624 | 22,782 | 21,844 |
| Reference price 2 | 463.54 | 512.97 | 471.56 | 368.90 | 350.55 | 424.43 | 424.43 | 424.43 |
| Nbr of stocks (in thousands) | 242,715 | 238,828 | 234,959 | 231,923 | 222,239 | 217,162 | - | - |
| Announcement Date | 26/01/22 | 25/01/23 | 24/01/24 | 23/01/25 | 28/01/26 | - | - | - |
1USD in Million2USD
Estimates
P/E ratio, Detailed evolution
| P/E (N) | EV / Sales (N) | EV / EBITDA (N) | Dividend Yield (N) | Capi.($) | ||
|---|---|---|---|---|---|---|
| 20.73x | 0.6x | 11.65x | 1.64% | 92.17B | ||
| 24.11x | 0.95x | 14.93x | 2.14% | 375B | ||
| 11.67x | 0.34x | 7.25x | 2.09% | 78.04B | ||
| 44.54x | 0.32x | 18.84x | 0.98% | 43.6B | ||
| 26.31x | 0.15x | 14.34x | -.--% | 32.69B | ||
| 60.81x | 0.21x | 13.61x | -.--% | 10.58B | ||
| 100.36x | 0.68x | 22.85x | -.--% | 3.97B | ||
| 326.73x | 0.72x | 35.93x | -.--% | 2.26B | ||
| 19.92x | 1.34x | 7.78x | -.--% | 2.02B | ||
| Average | 70.57x | 0.59x | 16.35x | 0.76% | 71.16B | |
| Weighted average by Cap. | 25.74x | 0.73x | 13.83x | 1.81% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- ELV Stock
- Valuation Elevance Health, Inc.
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition
















